Analysts have suggested that the benefit of semaglutide is similar to that seen with Madrigal Pharma's Rezdiffra (resmetirom), currently the only FDA-approved therapy for MASH, which is also known ...
Intercept Pharma’s obeticholic acid (OCA) – trying to become the first FDA-approved therapy for non ... was Madrigal Pharma’s resmetirom, which was able to reduce fibrosis and reduced ...
HealthDay on MSN1d
FDA Approves Susvimo for Diabetic Macular EdemaSusvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...
HealthDay on MSN1d
FDA Approves Symbravo for Acute Treatment of Migraine in AdultsWEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...
Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...
Novo Nordisk said on Wednesday it plan to file its experimental next-generation obesity drug CagriSema for regulatory ...
Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback